BioTelemetry, Inc. (NASDAQ:BEAT) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.
On March 4, 2019, BioTelemetry, Inc. issued a press release announcing the closing of the previously announced acquisition of Geneva Healthcare, Inc. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
ExhibitNumber |
ExhibitTitle |
|
Press release dated March 4, 2019 |
BIOTELEMETRY, INC. Exhibit
EX-99.1 2 beat34198kexhibit991.htm EXHIBIT 99.1 Exhibit Exhibit 99.1BioTelemetry,…
To view the full exhibit click here
